PTC Therapeutics Inc said a committee of the European Medicines Agency recommended against a conditional approval to its drug for the treatment of a rare muscular disorder, sending its shares down nearly 30 percent in premarket trading.
http://ift.tt/1ejh3AY
http://ift.tt/1ejh3AY
No comments:
Post a Comment